BLATT LAWRENCE 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-06 4:05 pm Purchase | 2023-10-25 | 13D | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 155,530 5.300% | 48,411 (+45.19%) | Filing |
| 2023-02-08 4:58 pm Purchase | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 107,119 6.500% | 6,744 (+6.72%) | Filing |
| 2022-02-10 4:15 pm Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 100,375 6.200% | 4,500 (+4.69%) | Filing |
| 2021-02-11 4:18 pm Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 95,875 6.700% | 95,875 (New Position) | Filing |